Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 27.73%2.12B | 27.68%1.39B | 25.53%653.82M | 6.93%2.36B | 1.25%1.66B | 4.61%1.09B | 0.67%520.86M | -19.12%2.21B | -21.66%1.64B | -26.25%1.04B |
| Operating revenue | 27.73%2.12B | 27.68%1.39B | 25.53%653.82M | 6.93%2.36B | 1.25%1.66B | 4.61%1.09B | 0.67%520.86M | -19.12%2.21B | -21.66%1.64B | -26.25%1.04B |
| Other operating revenue | ---- | 273.24%7.74M | ---- | 167.61%9.48M | ---- | 121.39%2.07M | ---- | 104.99%3.54M | ---- | -62.29%936.15K |
| Total operating cost | 30.86%2.04B | 32.16%1.34B | 30.52%623.9M | 10.21%2.21B | 3.71%1.56B | 4.17%1.01B | -0.95%478.01M | -11.24%2.01B | -11.49%1.5B | -13.49%972.83M |
| Operating cost | 32.35%1.89B | 32.42%1.24B | 30.37%576.03M | 10.28%2.01B | 4.69%1.43B | 6.79%935.08M | 4.02%441.86M | -12.91%1.82B | -13.63%1.36B | -16.19%875.61M |
| Operating tax surcharges | 8.45%10.92M | 20.96%7.65M | 13.69%3.28M | 8.91%12.84M | 7.91%10.07M | -2.09%6.33M | -8.96%2.88M | -21.97%11.79M | -17.50%9.33M | -20.21%6.46M |
| Operating expense | 11.58%20.67M | 9.48%12.27M | 12.17%5.33M | 10.63%28.8M | -5.90%18.53M | -12.89%11.21M | -10.47%4.75M | 15.57%26.03M | 32.12%19.69M | 42.35%12.86M |
| Administration expense | 10.91%69.08M | 32.49%49.23M | 41.74%23.62M | 14.12%95.35M | -9.25%62.29M | -21.27%37.16M | -27.38%16.66M | -10.89%83.55M | 1.17%68.63M | 6.18%47.2M |
| Financial expense | 121.21%661.23K | 74.45%-1.39M | 24.94%-1.48M | -66.65%-8.06M | 41.10%-3.12M | -38.93%-5.43M | -144.95%-1.97M | 86.64%-4.84M | 86.77%-5.29M | 83.40%-3.91M |
| -Interest expense (Financial expense) | ---- | ---- | ---- | -12.00%6.49M | ---- | ---- | ---- | 24.71%7.37M | ---- | ---- |
| -Interest Income (Financial expense) | 44.16%-1.49M | 42.57%-1.23M | 51.87%-681.74K | 56.68%-3.39M | 59.33%-2.68M | 45.00%-2.15M | 17.80%-1.42M | 58.51%-7.82M | 58.30%-6.58M | 65.21%-3.91M |
| Research and development | 13.98%52.74M | 14.66%33.3M | 23.90%17.13M | 7.64%72.82M | -6.78%46.27M | -16.07%29.04M | -37.13%13.83M | -7.35%67.66M | -27.30%49.64M | -17.17%34.6M |
| Credit Impairment Loss | 104.01%168.85K | 83.32%-260.28K | -9.48%-977.6K | -103.94%-13.49M | -13.22%-4.21M | -28.62%-1.56M | -146.96%-892.95K | -562.43%-6.61M | -71.14%-3.72M | -391.21%-1.21M |
| Asset Impairment Loss | ---- | ---- | ---- | 40.22%-25.26M | -398.61%-23.31M | -1,359.94%-23.31M | ---- | ---42.26M | ---4.68M | ---1.6M |
| Other net revenue | 960.26%28.19M | 218.94%15.52M | -21.95%5.19M | 87.35%-2.23M | -75.02%2.66M | -239.70%-13.05M | -7.23%6.64M | -271.20%-17.6M | 234.16%10.64M | 189.73%9.34M |
| Fair value change income | --1.47M | --1.04M | --535.6K | -1.17%1.81M | ---- | ---- | ---- | 864.52%1.83M | ---- | ---- |
| Invest income | -52.75%9.49M | -49.77%2.41M | -58.26%1.42M | 110.13%20.12M | 112.47%20.07M | 53.34%4.8M | 67.48%3.39M | 87.42%9.58M | 862.69%9.45M | 127.89%3.13M |
| Asset deal income | -1,208.01%-1.95M | -5,597.38%-1.95M | ---- | -76.43%82.04K | -65.75%176.26K | -93.74%35.52K | 125.11%28K | 739.89%348.1K | 39,279.20%514.69K | --567.17K |
| Other revenue | 91.54%19.02M | 104.24%14.28M | 2.32%4.21M | -25.66%14.51M | 9.43%9.93M | -17.30%6.99M | -26.62%4.12M | 202.03%19.52M | 96.67%9.07M | 261.75%8.45M |
| Operating profit | 4.18%105.65M | 6.82%67.84M | -29.09%35.1M | -20.45%143.09M | -29.94%101.41M | -18.98%63.51M | 17.95%49.49M | -62.13%179.87M | -63.36%144.74M | -73.09%78.39M |
| Add:Non operating Income | 526.69%975.65K | 484.98%710.1K | -51.75%13.2K | 1,836.00%806.42K | 604.64%155.68K | 501.91%121.39K | 52.22%27.36K | -87.07%41.65K | -86.15%22.09K | -37.75%20.17K |
| Less:Non operating expense | 146.12%2.04M | 179.83%1.93M | 6,398.89%887.19K | 144.25%7.77M | -72.58%828.7K | -38.14%688.31K | -98.29%13.65K | -0.99%3.18M | 130.92%3.02M | 0.33%1.11M |
| Total profit | 3.82%104.58M | 5.85%66.63M | -30.87%34.22M | -22.98%136.13M | -28.93%100.74M | -18.57%62.95M | 20.22%49.51M | -62.56%176.73M | -64.01%141.74M | -73.37%77.3M |
| Less:Income tax cost | -6.88%15.82M | 18.01%10.26M | -24.33%5.78M | -55.44%15.55M | -34.77%16.99M | -48.83%8.69M | -15.59%7.63M | -53.27%34.89M | -61.01%26.04M | -65.57%16.99M |
| Net profit | 5.99%88.77M | 3.90%56.37M | -32.07%28.45M | -14.99%120.58M | -27.61%83.75M | -10.05%54.25M | 30.29%41.87M | -64.30%141.84M | -64.62%115.69M | -74.97%60.31M |
| Net profit from continuing operation | 5.99%88.77M | 3.90%56.37M | -32.07%28.45M | -14.99%120.58M | -27.61%83.75M | -10.05%54.25M | 30.29%41.87M | -64.30%141.84M | -64.62%115.69M | -74.97%60.31M |
| Net profit of parent company owners | 5.99%88.77M | 3.90%56.37M | -32.07%28.45M | -14.99%120.58M | -27.61%83.75M | -10.05%54.25M | 30.29%41.87M | -64.33%141.84M | -64.65%115.69M | -74.98%60.31M |
| Earning per share | ||||||||||
| Basic earning per share | 4.06%0.4123 | 4.72%0.2618 | -34.57%0.1302 | -15.08%0.5678 | -27.20%0.3962 | -11.63%0.25 | 34.64%0.199 | -63.62%0.6686 | -63.99%0.5442 | -74.63%0.2829 |
| Diluted earning per share | 4.06%0.4123 | 4.72%0.2618 | -34.57%0.1302 | -15.08%0.5678 | -27.20%0.3962 | -11.63%0.25 | 34.64%0.199 | -63.62%0.6686 | -63.99%0.5442 | -74.63%0.2829 |
| Other composite income | -93.32%1.01M | -91.24%1.01M | -90.73%1.01M | 211.16%15.1M | 245.32%11.5M | 315.45%10.86M | ||||
| Other composite income of parent company owners | ---- | ---- | ---- | -93.32%1.01M | -91.24%1.01M | -90.73%1.01M | ---- | 211.16%15.1M | 245.32%11.5M | 315.45%10.86M |
| Total composite income | 4.73%88.77M | 2.01%56.37M | -32.07%28.45M | -22.53%121.59M | -33.36%84.76M | -22.36%55.26M | 30.33%41.87M | -59.10%156.94M | -60.15%127.19M | -69.83%71.17M |
| Total composite income of parent company owners | 4.73%88.77M | 2.01%56.37M | -32.07%28.45M | -22.53%121.59M | -33.36%84.76M | -22.36%55.26M | 30.33%41.87M | -59.13%156.94M | -60.17%127.19M | -69.85%71.17M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.